To view this email as a web page, click here.
 
New naloxone to provide more opioid overdose options
Pharmacy and healthcare experts cautiously praised the planned development of a fast-acting, better version of naloxone (Narcan), which is used to reverse the effects of opioid overdoses.
Read more
 
New migraine prevention drug faces competition
While Teva Pharmaceutical’s new migraine prevention drug is unique, it faces competition from another major migraine treatment.
Read more
 
Pharma exec defends 400% price hike
Reminiscent of former Turing Pharmaceuticals CEO Martin Shrekli, a different pharma executive defended his company’s 400% price hike on an antibiotic.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.